Status:
COMPLETED
A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions
Lead Sponsor:
Paddock Laboratories, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study was to evaluate the relative bioavailability of Paddock Laboratories, Inc.'s test formulation of Moexipril/ Hydrochlorothiazide 15mg/25mg tablets with a reference formulation...
Eligibility Criteria
Inclusion
- Good health as determined by lack of clinically significant abnormalities in health assessments performed at screening
Exclusion
- Positive test results for HIV or Hepatitis B or C
- History of allergy or sensitivity to Moexipril, Hydrochlorothiazide or related drugs
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00990301
Last Update
November 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novum Pharmaceutical Research Services
Pittsburgh, Pennsylvania, United States, 15206